Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-100219
Filing Date
2021-03-30
Accepted
2021-03-30 16:45:52
Documents
4
Period of Report
2021-05-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A d137834ddef14a.htm DEF 14A 296888
2 GRAPHIC g137834g30h04.jpg GRAPHIC 23855
3 GRAPHIC g137834g35z61.jpg GRAPHIC 110094
4 GRAPHIC g137834g83m44.jpg GRAPHIC 120070
  Complete submission text file 0001193125-21-100219.txt   644964
Mailing Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101
Business Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 033-80623 | Film No.: 21786594
SIC: 2835 In Vitro & In Vivo Diagnostic Substances